SCHEMBL29587388

SCHEMBL29587388

COc1cc(F)cc(C(=O)N2CCc3nc(-c4ccccn4)ncc3C2)c1

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 2/20 0.54
KDR P35968 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21326063 1.00 PDGFRB (0.54) PDGFRBKDR
SCHEMBL21326002 0.94 PDGFRB (0.61) PDGFRBKDR
SCHEMBL29587423 0.94 PDGFRB (0.61) PDGFRBKDR
SCHEMBL21325971 0.91 HSP90AB1 (0.56) KDR
SCHEMBL29586847 0.91 HSP90AB1 (0.56) KDR
SCHEMBL29587109 0.89 PDGFRB (0.54) PDGFRBKDR
SCHEMBL21326021 0.89 PDGFRB (0.54) PDGFRBKDR
SCHEMBL21326027 0.87 PDGFRB (0.54) PDGFRBKDR
SCHEMBL29587115 0.87 PDGFRB (0.54) PDGFRBKDR
SCHEMBL21326001 0.87 PDGFRB (0.60) PDGFRBKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110088103-B Novel tetrahydropyridopyrimidine compounds for the treatment and prophylaxis of hepatitis b virus infection 豪夫迈·罗氏有限公司 2022-04-12 CN claimed
CN-110088103-B Novel tetrahydropyridopyrimidine compounds for the treatment and prophylaxis of hepatitis b virus infection 豪夫迈·罗氏有限公司 2022-04-12 CN disclosed